| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96b882006e755dfc56fcabfc5fb019f6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate |
2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace24bd4d63fc6f3de2fc2cbe6475dff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e8b9ba31e69668cb39fef1369bcb70f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c5e47a84a9eef4a1ae0f8cfe5c7fa98 |
| publicationDate |
2011-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-PI0515862-A2 |
| titleOfInvention |
use of phentermine and 5ht-2c receptor selective agonist in the preparation of compositions, 5ht-2c receptor modulating compositions and unit dosage form comprising the same |
| abstract |
USE OF PHENTERMIN AND 5HT-2C RECEIVER SELECTIVE AGONIST IN PREPARING COMPOSITIONS, 5HT-2C RECEIVER MODULATOR COMPOSITIONS AND UNIT FORMS UNDERSTANDING THE SAME. The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. Further, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having formula (1) or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes treating obesity. |
| priorityDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |